New research has linked a TNFSF13B variant and B cell activating factor (BAFF), a common therapeutic target, with multiple sclerosis and systemic lupus erythematosus. The variant is a disease-risk allele associated with increased levels of soluble BAFF…
![](https://www.the-rheumatologist.org/wp-content/uploads/2016/05/iStock_TestTubes_Generic_500x270-150x150.jpg)